Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. Kline (1954)
Use of Rauwolfia serpentina Benth. in neuropsychiatric conditions.Annals of the New York Academy of Sciences, 59 1
N. Kline, A. Stanley (1955)
USE OF RESERPINE IN A NEUROPSYCHIATRIC HOSPITALAnnals of the New York Academy of Sciences, 61
J. A. Barsa (1955)
Treatment of 200 Disturbed Psychotics with ReserpineJ. A. M. A., 158
Barsanti Ja, Kline Ns (1956)
Agranulocytosis while receiving combined reserpine-chlorpromazine therapy; report of two cases.Diseases of the nervous system, 17
J. Barsa, N. Kline (1956)
Use of reserpine in disturbed psychotic patients.The American journal of psychiatry, 112 9
E. Gosline
Use of Reserpine on an Admission Service, Report
J. Barsa, N. Kline (1955)
Reserpine in the treatment of psychotics with convulsive disorders.A.M.A. archives of neurology and psychiatry, 74 1
J. A. Barsa (1955)
Reserpine in the Treatment of Psychotics with Convulsive DisordersA. M. A. Arch. Neurol. & Psychiat., 74
N. S. Kline
Psychiatry-Pharmacology: Recent Advances
G. Nicolaou
Reserpine in Disturbed Adolescents, Report
J. M. Müller , E. Schlittler (1952)
Reserpin, der sedative Wirkstoff aus Rauwolfia serpentina Benth.Experientia, 8
J. Barsa, N. Kline (1955)
Combined reserpine-chlorpromazine therapy in disturbed psychotics.American Journal of Psychiatry, 111
J. Barsa, N. Kline (1955)
Treatment of two hundred disturbed psychotics with reserpine.Journal of the American Medical Association, 158 2
J. A. Barsa (1955)
Combined Reserpine-Chlorpromazine Therapy in Disturbed Psychotics: Preliminary ReportAm. J. Psychiat., 111
Abstract Great interest has recently been centered on two new drugs for the treatment of mental disorders, chlorpromazine and reserpine. The former, a synthetic, was used in Europe for several years before it was finally introduced into this country. Reserpine is a crystalline alkaloid extracted from the root of the plant Rauwolfia serpentina Benth. This plant was used for centuries in India for the treatment of a wide variety of diseases, including mental disorders. It was introduced into this country for its use in the management of hypertension. In 1952, Müller, Schlittler, and Bein1 identified reserpine, which appeared to be the chief active principle of Rauwolfia. We have reported elsewhere * our experiences with reserpine alone in the treatment of disturbed psychotics. Chlorpromazine also has the property of potentiating the effects of hypnotics and sedatives. Because of this, we decided to investigate the effect of combining reserpine and chlorpromazine. At first References 1. References 2 to 9. 2. References 3, 4, and 5. 3. Müller, J. M.; Schlittler, E., and Bein, H. J.: Reserpin, der sedative Wirkstoff aus Rauwolfia serpentina Benth. , Experientia 8:338, 1952.Crossref 4. Kline, N. S.: Use of Rauwolfia Serpentina Benth. in Neuropsychiatric Conditions , Ann. New York Acad. Sc. 59:107, 1954.Crossref 5. Barsa, J. A., and Kline, N. S.: Use of Reserpine in Disturbed Psychotic Patients , Am. J. Psychiat. , to be published. 6. Barsa, J. A., and Kline, N. S.: Treatment of 200 Disturbed Psychotics with Reserpine , J. A. M. A. 158:110, 1955.Crossref 7. Barsa, J. A., and Kline, N. S.: Reserpine in the Treatment of Psychotics with Convulsive Disorders , A. M. A. Arch. Neurol. & Psychiat. 74: 31, 1955. 8. Gosline, E., and Kline, N. S.: Use of Reserpine on an Admission Service, Report , American Psychiatric Association, Regional Research Conference, Galveston, Texas, to be published. 9. Nicolaou, G., and Kline, N. S.: Reserpine in Disturbed Adolescents, Report , American Psychiatric Asssociation, Regional Research Conference, Galveston, Texas, to be published. 10. Kline, N. S., and Stanley, A. M.: Use of Reserpine in a Neuropsychiatric Hospital , Ann. New York Acad. Sc. 61:85, 1955. 11. Kline, N. S.: Psychiatry-Pharmacology: Recent Advances , American Association for Advancement of Science, Monograph, to be published. 12. Barsa, J. A., and Kline, N. S.: Combined Reserpine-Chlorpromazine Therapy in Disturbed Psychotics: Preliminary Report , Am. J. Psychiat. 111:780, 1955. 13. Barsa, J. A., and Kline, N. S.: Agranulocytosis While Receiving Combined Reserpine-Chlorpromazine Therapy: Report of 2 Cases , Dis. Nerv. System , to be published.
A.M.A. Archives of Neurology & Psychiatry – American Medical Association
Published: Sep 1, 1955
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.